Hospiten News

Check the latest news

Hospiten incorporates the first three digital magnetic resonance machines in Tenerife and Lanzarote

Posted on 14-05-2019

This state-of-the-art equipment helps improve the patient experience and provides better image quality

The Hospiten Group takes a new leap in its innovation strategy and incorporates the first three digital magnetic resonance machines in Tenerife and Lanzarote - state-of-the-art equipment that helps improve patient experience and provides better quality mages.

The three new, fully digital pieces of equipment (Philips Inginia Prodiva 1.5 and Philips Ingenia HP 1.5 T), for Hospiten Sur, Hospiten Rambla and Hospiten Lanzarote, give improved experience in clinical tests and medical specialties thanks to technological developments which provide intelligent data on how the body is functioning and can, therefore, give a rapid, non-invasive, accurate diagnosis. The new models are also designed to obtain high-quality images in complex areas like neurology, skeletal muscle, breast and oncology.

The new systems stand out when compared to conventional MRI in that there is a better lit and more ample space for the patient, between 70 – 110 cm wider, and the time needed for preparation and carrying out the procedure is reduced. The new equipment is also less sensitive to restless or nervous patients, avoiding the need to repeat tests.

This new system represents an important advance in image diagnosis since the results are more accurate, provide more information and mean that tests take considerably less time. That means the process is shorter, more precise and less stressful for the patient.

The Hospiten Group is an international healthcare group committed to providing top quality service, with 50 years’ experience and twenty private medical-hospital centers in Spain, the Dominican Republic, Mexico, Jamaica and Panama, and over a hundred ambulatory health centers under the brand Clinic Assist. Dr. Pedro Luis Cobiella is president of the group which every year attends more than 1,700,000 patients from all over the world and employs over 5,000 people.